FDA.reportPublic FDA data

Application 205869

Type
ANDA
Sponsor
BEIJING YILING

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LETROZOLELETROZOLETABLET;ORAL2.5MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
62135-491LETROZOLELetrozoleChartwell RX, LLCANDACurrent
62135-491LETROZOLELetrozoleChartwell RX, LLCANDACurrent
69117-0004LetrozoleLetrozole TabletsYiling Pharmaceutical, Inc.ANDACurrent
69117-0004LetrozoleLetrozole TabletsYiling Pharmaceutical, Inc.ANDACurrent
69117-0004LetrozoleLetrozole TabletsYiling Pharmaceutical, Inc.ANDACurrent
69117-0004LetrozoleLetrozole TabletsYiling Pharmaceutical, Inc.ANDACurrent
69117-0004LetrozoleLetrozole TabletsYiling Pharmaceutical, Inc.ANDACurrent
69117-0004LetrozoleLetrozole TabletsYiling Pharmaceutical, Inc.ANDACurrent